Continuously evolving venues, methods, and targets of patent litigation; the new USPTO director; patent reform bills … these are just a few factors challenging Japanese IP executives’ already complex task of trying to manage their global IP footprint smarter.
In this half-day, complimentary seminar, former USPTO Director Jon W. Dudas and a group of U.S., Japanese, and Chinese IP attorneys experienced in advising Japanese corporations decipher what really matters for Japanese businesses as U.S. patent procurement and enforcement regimes are being radically restructured. The topics included:
- The New Administration and Director Kappos – What Happens Next?
- The effect on the Patent Reform Act of 2009
- What will become of the Tafas v. Doll rules package and the interpretation of Bilski?
- How might the rules on inter partes reexamination be tightened?
- Strategic Use of Inter Partes Reexamination in Patent Litigation
- In synergy with expected procedural changes under the new USPTO director, the very high kill ratio of patents makes inter partes reexamination a very attractive alternative or parallel to district court litigation
- Pros and cons vs. alternatives
- Mistakes to avoid
- Strategic Measures for Effective and Efficient U.S. Patent Litigation
- Focused discovery, management controls, and other tactical measures to achieve litigation goals without undue costs
- Positioning a company to exit litigation early
- Latest considerations for transferring away from certain “Rocket Dockets”
- Chinese Infringement Under the Third Amendment:
- Milestones for claim and patent application drafting and claim interpretation based on the draft interpretation of patent infringement principles issued by the highest court in China
- Comparative analyses of the Chinese patent law with reference to Japanese and U.S. patent principles
Guest Speakers
- Dr. Hiroshi Akimoto, former Managing Director, Takeda Pharmaceutical Company, Ltd.
- Shozo Uemura, former Deputy Director General, WIPO
Foley Speakers
- Jon W. Dudas, former Director of USPTO and Partner, IP Litigation
- Pavan K. Agarwal, Partner and Chair, Electronics
- Etsuo Doi, Partner, Electronics, Tokyo
- Stephen B. Maebius, Partner and Co-Chair, Life Sciences Industry Team
- Prof. Harold C. Wegner, Partner, Chemical & Pharmaceutical
- Yan Zhao, Senior Counsel, Electronics, Shanghai
For specific information on the content of this seminar, contact Konomi Kaji at kkaji@foley.com.
People
Related Insights
June 10, 2025
Foley Viewpoints
EPA to Approve Texas use of CO2 Sequestration Wells
Today, the EPA took an important step in allowing Texas to issue permits for Class VI wells within the state. Class VI wells are used for…
June 10, 2025
Foley Viewpoints
Supreme Court Rejects Minimum Contacts Requirement to Subject Foreign States to Suits in the U.S. Under FSIA
On June 5, 2025, in a unanimous decision authored by Justice Alito, the United States Supreme Court held that the Foreign Sovereign Immunities Act of 1976 (FSIA), 28 U.S.C. §§1330, 1602 et seq., does not require a plaintiff to prove a foreign state has made “minimum contacts” with the United States sufficient to satisfy the personal jurisdiction test set forth in International Shoe Co. v. Washington, 326 U.S. 310, 316 (1945).
June 10, 2025
Foley Ignite
Investor Insights: An Overview of PitchBook’s H1 2025 VC Tech Survey
Having done a deep dive into PitchBook’s H1 2025 VC Tech Survey, not to mention living and breathing the state of venture with my clients who are in market for capital, I wanted to share my thoughts about how investors appear to be recalibrating their approach to technology startups.